MSA MSA Safety Inc
Orthopedic, Prosthetic & Surgical Appliances & Supplies · NYSE · SEC CIK 66570 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY8.1%
TTM net income YoY8.2%
TTM EPS YoY9.7%
Revenue 3-yr CAGR5.1%
Net income 3-yr CAGR108.0%
Margins
Gross margin47.3%
Operating margin20.2%
Net margin15.0%
FCF margin16.0%
EBITDA margin24.1%
Returns
ROE22.1%
ROA10.4%
ROIC (approx.)14.9%
Asset turnover0.69x
Leverage & solvency
Liabilities / assets56.3%
Debt / equity0.78x
Current ratio2.65x
Interest coverage10.76x
Cash quality & payout
Operating cash flow / net income1.24x
Accruals ratio-2.5%
Payout ratio27.4%
Capex / revenue2.7%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | 2026Q32026-09-30 | 2026Q22026-06-30 | 2026Q12026-03-31 | 2025Q42025-12-31 | 2025Q32025-09-30 | 2025Q22025-06-30 | 2025Q12025-03-31 | 2024Q42024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $536.43M | $503.33M | $463.63M | $510.91M | $468.44M | $474.12M | $421.34M | $499.70M |
| Cost of revenue | $292.20M | $254.04M | $244.05M | $271.52M | $250.83M | $253.41M | $227.94M | $265.27M |
| Gross profit | $244.23M | $249.29M | $219.58M | $239.39M | $217.62M | $220.71M | $193.40M | $234.43M |
| R&D expense | $19.96M | $19.15M | $16.36M | $16.16M | $16.52M | $17.00M | $15.67M | $16.83M |
| SG&A expense | $132.38M | $114.07M | $107.68M | $105.36M | $102.85M | $112.08M | $93.97M | $100.38M |
| Operating income | $88.23M | $111.96M | $93.01M | $113.89M | $94.31M | $85.86M | $77.76M | $117.64M |
| Interest expense | $13.76M | $7.95M | $7.70M | $8.43M | $8.42M | $8.12M | $6.83M | $7.33M |
| Pretax income | $81.95M | $111.39M | $92.99M | $113.25M | $92.46M | $82.75M | $77.95M | $116.81M |
| Income tax | $23.56M | $25.19M | $21.72M | $26.32M | $22.84M | $19.97M | $18.34M | $28.87M |
| Net income | $58.40M | $86.19M | $71.27M | $86.93M | $69.61M | $62.77M | $59.60M | $87.95M |
| EBITDA | $111.24M | $131.28M | $111.37M | $132.54M | $112.89M | $103.96M | $94.01M | $134.41M |
| EPS (basic) | 1.51 | 2.23 | 1.83 | 2.22 | 1.78 | 1.60 | 1.51 | 2.23 |
| EPS (diluted) | 1.51 | 2.23 | 1.83 | 2.21 | 1.77 | 1.59 | 1.51 | 2.22 |
| Dividends declared per share | 0.54 | 0.54 | 0.53 | 0.53 | 0.53 | 0.53 | 0.51 | 0.51 |
| Weighted avg. shares (diluted) | 38.65M | 38.70M | 38.99M | — | 39.28M | 39.36M | 39.50M | — |
| Balance sheet | ||||||||
| Cash & equivalents | $187.25M | $200.06M | $180.16M | $165.07M | $170.00M | $146.99M | $170.62M | $165.10M |
| Receivables | $374.21M | $347.88M | $325.01M | $306.45M | $306.95M | $333.75M | $294.42M | $279.21M |
| Inventory | $370.60M | $350.12M | $352.31M | $343.04M | $355.49M | $343.88M | $306.68M | $296.80M |
| Current assets | $990.74M | $934.84M | $891.67M | $869.29M | $894.77M | $887.46M | $823.16M | $803.03M |
| PP&E, net | $282.27M | $276.69M | $278.06M | $283.06M | $278.48M | $279.42M | $211.71M | $211.87M |
| Goodwill | $1.04B | $726.05M | $727.44M | $731.59M | $732.22M | $733.25M | $627.20M | $620.89M |
| Intangibles | $558.57M | $285.72M | $291.99M | $299.13M | $304.50M | $310.93M | $243.80M | $246.44M |
| Total assets | $3.28B | $2.60B | $2.56B | $2.55B | $2.55B | $2.55B | $2.24B | $2.21B |
| Current liabilities | $373.70M | $288.90M | $281.27M | $289.21M | $290.27M | $285.46M | $280.44M | $288.09M |
| Short-term debt | $33.10M | $8.10M | $8.07M | $8.22M | $8.21M | $8.38M | $32.89M | $26.39M |
| Long-term debt | $1.09B | $591.65M | $605.08M | $572.71M | $620.37M | $670.97M | $469.17M | $481.62M |
| Total debt | $1.12B | $599.74M | $613.15M | $580.93M | $628.58M | $679.35M | $502.06M | $508.01M |
| Total liabilities | $1.84B | $1.20B | $1.21B | $1.19B | $1.25B | $1.30B | $1.05B | $1.06B |
| Shareholders' equity | $1.43B | $1.40B | $1.36B | $1.37B | $1.30B | $1.25B | $1.19B | $1.14B |
| Net debt | $933.96M | $399.69M | $432.99M | $415.87M | $458.58M | $532.36M | $331.44M | $342.92M |
| Shares outstanding | 38.54M | 38.60M | 38.73M | 38.91M | 39.15M | 39.14M | 39.30M | 39.26M |
| Cash flow statement | ||||||||
| Operating cash flow | $82.31M | $95.38M | $75.69M | $122.35M | $112.46M | $67.22M | $61.83M | $107.91M |
| Capital expenditure | $14.13M | $12.67M | $10.59M | $16.33M | $11.99M | $29.33M | $10.78M | $14.41M |
| Free cash flow | $68.18M | $82.70M | $65.10M | $106.02M | $100.48M | $37.88M | $51.05M | $93.50M |
| Investing cash flow | -$577.22M | -$12.67M | -$10.55M | -$17.77M | -$11.99M | -$217.11M | -$10.77M | -$14.03M |
| Financing cash flow | $487.96M | -$58.73M | -$47.22M | -$107.64M | -$71.81M | $119.59M | -$45.61M | -$72.52M |
| Depreciation & amortization | $23.01M | $19.32M | $18.35M | $18.66M | $18.59M | $18.10M | $16.25M | $16.77M |
| Stock-based compensation | $7.64M | $7.81M | $3.81M | $3.85M | $3.35M | $5.37M | $2.63M | $4.74M |
| Dividends paid | $20.83M | $20.85M | $20.56M | $20.71M | $20.76M | $20.85M | $20.03M | $20.09M |
Free plan shows the latest 8 periods; Pro shows all 70 🔒
· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.